3.49

5.12% 0.17

After Hours: 3.48 -0.01 -0.29%

Achieve Life Sciences Inc (ACHV)

Overview News Price History Option Chain Financials Why ACHV Down? Discussions Forecast Stock Split

Achieve Life Sciences Inc stock is traded at $3.49, with a volume of 567.22K. It is up +5.12% in the last 24 hours and down -18.46% over the past month. Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Previous Close:

$3.32

Open:

$3.33

24h Volume:

567.22K

Relative Volume:

0.86

Market Cap:

$185.81M

Revenue:

Net Income/Loss:

$-54.65M

P/E Ratio:

-2.6954

EPS:

-1.2948

Net Cash Flow:

$-49.47M

1W Performance:

+8.05%

1M Performance:

-18.46%

6M Performance:

+13.31%

1Y Performance:

+66.99%

1-Day Range:

$3.30

$3.49

1-Week Range:

$3.09

$3.49

52-Week Range:

$1.95

$6.025

Achieve Life Sciences Inc Stock (ACHV) Company Profile

Name

Achieve Life Sciences Inc

Sector

Healthcare (1106)

Industry

Biotechnology (623)

Phone

425-686-1500

Address

22722 29TH DR. SE, SEATTLE, BC

Employee

Twitter

Next Earnings Date

2026-03-24

Latest SEC Filings

ACHV's Discussions on Twitter

Compare ACHV vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACHV Achieve Life Sciences Inc	3.49	176.76M	0	-54.65M	-49.47M	-1.2948
VRTX Vertex Pharmaceuticals Inc	436.27	113.64B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	748.87	81.18B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	799.65	49.78B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	322.11	42.87B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	309.66	34.79B	5.36B	287.73M	924.18M	2.5229

Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-25-25	Initiated	Citizens JMP	Mkt Outperform
Aug-21-25	Initiated	H.C. Wainwright	Buy
Nov-14-24	Initiated	Rodman & Renshaw	Buy
Sep-27-24	Initiated	Raymond James	Strong Buy
May-10-23	Reiterated	Maxim Group	Buy
Jun-23-21	Initiated	Oppenheimer	Outperform

View All

Achieve Life Sciences Inc Stock (ACHV) Latest News

Apr 10, 2026

Aug Big Picture: Is Achieve Life Sciences Inc stock forming a triangle patternInsider Selling & Real-Time Volume Spike Alerts - baoquankhu1.vn

Apr 10, 2026

Nicotine dependence therapy research advances as Achieve Life Sciences, Inc. pushes for new solutions - Traders Union

Apr 10, 2026

Apr 09, 2026

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2025 earnings call transcript - MSN

Apr 09, 2026

Apr 08, 2026

Stock Recap: What is Achieve Life Sciences Incs book value per shareQuarterly Investment Review & AI Powered Market Entry Strategies - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026